The Olofsson lab studies peripheral nerve regulation of inflammation. More information is available at https://ki.se/en/meds/research-group-peder-olofsson.
Discoveries in neuroscience and immunology have revealed that interactions between peripheral nerves and immune cells regulate inflammation. While the insights are already used in clinical trials, the mechanisms are not fully understood.
Our work has contributed to an improved understanding of the neuro-immune crosstalk in inflammation, for example how peripheral nerves regulate inflammation and how acetylcholine-producing T cells control vascular function and anti-microbial defense.
We work in a highly ambitious and friendly environment that promotes high-quality science and supports career advancement.
The lab is well-equipped for immunobiology research with easy access to advanced imaging, cell sorting, and animal work platforms. We also have strong national and international collaborations and are part of multiple consortia within Sweden, the European Union, and North America.
The primary objective of this post-doctoral position is to investigate the interactions between peripheral nerves and immune cells in experimental inflammation. You will work both independently and collaboratively with other lab members, utilizing systems for inducible gain- or loss-of-function of peripheral nerves and immune cells to explore neuro-immune crosstalk.
We strive to provide opportunities for you to develop your own project ideas within this subject area and build a strong foundation for a career in science. Accordingly, presentations of the work at international scientific conferences and in well-respected journals are strongly encouraged.
Requirements include
It is particularly meriting that the applicant
To be eligible for employment as a postdoctor a phd or a foreign degree deemed to be equivalent to a Swedish phd is required. This eligibility requirement must be fulfilled at the latest at the time of the employment decision. It is considered as an advantage if you have completed your doctoral degree within the last three years, if there are special reasons, your degree may have been completed earlier.
A creative and inspiring environment with wide-ranging expertise and interests. Karolinska Institutet is one of the world's leading medical universities. At Karolinska Institutet, we conduct successful medical research and hold the largest range of medical education in Sweden. At KI, you get to meet researchers working with a wide range of specialisms and methods, giving you ample opportunity to exchange knowledge and experience with the various scientific fields within medicine and health. It is the crossover collaborations, which have pushed KI to where it is today, at the forefront of global research. Several of the people you meet in healthcare are educated at KI. A close relationship with the health care providers is important for creating groundbreaking top quality education and research. Karolinska Institutet is also a state university, which entitles you to several benefits through our collective agreement.
The position is located within the Department of Medicine, Solna. The department consists of ten divisions and each division consists of several research groups. The position is located within the research group of Peder Olofsson within the Division of Cardiovascular Medicine. Web: https://ki.se/en/meds/research-group-peder-olofsson.
--- [Video about a Karolinska Institutet, how we work towards "a better health for all"] --
An employment application must contain the following documents in English or Swedish:
The application is to be submitted through the Varbi recruitment system.
Type of employment | Temporary position |
---|---|
Contract type | Full time |
First day of employment | According to agreement |
Salary | Monthly salary |
Number of positions | 1 |
Full-time equivalent | 100 % |
City | Stockholm |
County | Stockholms län |
Country | Sweden |
Reference number | STÖD 2-5075/2024 |
Contact |
|
Union representative |
|
Published | 17.Dec.2024 |
Last application date | 08.Jan.2025 11:59 PM CET |